225. 先天性腎性尿崩症 Congenital nephrogenic diabetes insipidus Clinical trials / Disease details

臨床試験数 : 15 / 薬物数 : 48 - (DrugBank : 18) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 65

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05044611 (ClinicalTrials.gov)	April 1, 2022	27/8/2021	AMIloridefor the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Trea ...	AMIloridefor the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Trea ...	Bipolar Disorder	Drug: Anhydrous Amiloride Hydrochloride;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	N/A	All	148	Phase 4	NULL
2	EUCTR2006-001202-84-NL (EUCTR)	01/02/2007	31/01/2007	Comparison of the action of amilorideand thiazide in the reduction of lithium-NDI in patients with a ...	Comparison of the action of amilorideand thiazide in the reduction of lithium-NDI in patients with a ...	Lithium-induced Nephrogenic Diabetes Insipidus MedDRA version: 9.1;Level: LLT;Classification code 10 ...	Trade Name: Midamor Product Name: Amiloride Trade Name: Hydrochloorthiazide Product Name: hydrochloorth ...	Radboud University Nijmegen Medical Centre	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 4	Netherlands

First Previous1Next Last